Session R.A. II

Track

Insider profile

Performance

Overall performance
1.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 93% 68% 82%
Transactions
8 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -94%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Session R.A. II's trades of Taysha Gene Therapies Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-14 2023-07-13
S Sale
3,969 +46.0%
110.32
US$1,242,836 		3,969 +46.0% 110.32 US$1,242,836
2023-07-14 2023-07-12
S Sale
36,851 +18.3%
499.93
US$2,834,980 		36,851 +18.3% 499.93 US$2,834,980
2023-06-26 2023-06-23
S Sale
84,415 -12.1%
127.60
US$366,054 		84,415 -12.1% 127.60 US$366,054
2023-06-26 2023-06-22
S Sale
10,508 -0.1%
0.70
US$7,384 		10,508 -0.1% 0.70 US$7,384
2023-06-22 2023-06-21
S Sale
138,962 -1.5%
0.70
US$97,635 		138,962 -1.5% 0.70 US$97,635
2023-06-22 2023-06-20
S Sale
295,653 -3.1%
0.71
US$210,209 		295,653 -3.1% 0.71 US$210,209
2023-06-20 2023-06-20
PrS Proposed sale
1,006,000
0.70
US$699,572 		1,006,000 0.70 US$699,572
2023-06-20 2023-06-20
PrS Proposed sale
1,006,000
0.70
US$699,572 		1,006,000 0.70 US$699,572
2021-12-08 2021-11-23
B Purchase
26,008 +0.3%
12.65
US$329,001 		26,008 +0.3% 12.65 US$329,001
2021-12-08 2021-11-23
B Purchase
16,510 +0.2%
12.12
US$200,101 		16,510 +0.2% 12.12 US$200,101